Quest
Quest Diagnostics Wins CDC Contracts for Avian Flu, Oropouche Testing
Quest has developed a multi-target molecular test for avian influenza A H5 virus that it plans to make available by the end of October.
Quest's Haystack Oncology, U of Montreal to Study Liquid Biopsy MRD Test in Colorectal Cancer
The partners will use Haystack's MRD test to assess treatment response and detect early relapse in colorectal cancer patients with liver metastasis.
Despite Broad Carve-Outs, FDA Final Rule on LDTs Draws Critical Response From Lab Industry
The rule makes explicit that LDTs are subject to FDA oversight but provides for enforcement discretion across a broad range of tests.
Cancer Sequencing Labs, Advocacy Groups Partner to Increase Genetic Testing Access
The newly launched INTERACT coalition said it will try to press medical and industry guidelines to keep pace with evidence surrounding inherited cancer risk.
Quest Diagnostics, Ultima Genomics Team Up to Develop Clinical Sequencing Tests
Quest will use Ultima's high-throughput sequencing tech to develop MRD detection tests in solid tumors and potentially for rare disease diagnosis.
Nov 11, 2022
Oct 20, 2022